Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
51.1M
-
Number of holders
-
71
-
Total 13F shares, excl. options
-
16.9M
-
Shares change
-
-405K
-
Total reported value, excl. options
-
$237M
-
Value change
-
+$3.1M
-
Number of buys
-
41
-
Number of sells
-
-29
-
Price
-
$14.01
Significant Holders of REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) as of Q3 2016
79 filings reported holding RGNX - REGENXBIO Inc. - Common Stock, par value $0.0001 per share as of Q3 2016.
REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) has 71 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16.9M shares
of 51.1M outstanding shares and own 33.13% of the company stock.
Largest 10 shareholders include BROOKSIDE CAPITAL MANAGEMENT LLC (2.47M shares), PERCEPTIVE ADVISORS LLC (1.28M shares), JPMORGAN CHASE & CO (1.01M shares), FRANKLIN RESOURCES INC (991K shares), Vivo Capital, LLC (990K shares), FMR LLC (860K shares), VANGUARD GROUP INC (766K shares), BlackRock Advisors LLC (694K shares), BlackRock Fund Advisors (570K shares), and PRICE T ROWE ASSOCIATES INC /MD/ (527K shares).
This table shows the top 71 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.